For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals.
"synopsis" may belong to another edition of this title.
Roland Kontermann obtained his PhD in Molecular Biology from the University of Heidelberg. After working as a postdoc in the laboratory of Sir Gregory Winter at the MRC Centre for Protein Engineering, Cambridge, UK, he was a group leader at the Institute of Molecular Biology and Tumor Biology of the University of Marburg, and subsequently Head of Research at vectron therapeutics AG. Since 2004 he is Professor of Biomedical Engineering at the Institute of Cell Biology and Immunology of the University of Stuttgart. Current research focuses on the development of recombinant bispecific and bifunctional antibody molecules, including half-life extension strategies, and targeted nanoparticulate carrier systems for tumor therapy. He has over 60 scientific publications and co-editor (together with Stefan D�bel) of the Antibody Engineering Lab Manual.
Review:"The majority of future protein therapeutics will be modified in one way or another using techniques and concepts described in this monograph. Therefore it can be safely stated that this is an extremely relevant contribution, which should be on hand for all those who think about or work on protein therapeutics." (Biotechnology Journal, Nov 2012)
"About this title" may belong to another edition of this title.
Book Description Condition: New. Seller Inventory # 12320532-n
Book Description Wiley-VCH 2012-02-22, Weinheim :|Chichester, 2012. hardback. Condition: New. Seller Inventory # 9783527328499
Book Description John Wiley and Sons. Condition: New. Brand New. Seller Inventory # 3527328491
Book Description Wiley-Blackwell, 2012. Condition: New. Seller Inventory # L9783527328499
Book Description Wiley-Blackwell, 2012. Hardcover. Condition: New. 1. Seller Inventory # DADAX3527328491
Book Description Vch Verlagsgesellschaft Mbh, 2012. Hardcover. Condition: Brand New. 1st edition. 372 pages. 9.76x6.85x0.87 inches. In Stock. Seller Inventory # __3527328491
Book Description Wiley VCH Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals. 354 pp. Englisch. Seller Inventory # 9783527328499
Book Description Wiley VCH Verlag Gmbh Feb 2012, 2012. Buch. Condition: Neu. Neuware - For this ready reference, the internationally renowned authority in the field, Roland Kontermann, has assembled a team of outstanding contributors from industry and academia to convey the worldwide knowledge on modifying therapeutic proteins in order to optimize their pharmacological potential. The result is a comprehensive work covering all approaches and aspects of the topic in one handy volume, making this indispensable reading for companies and research institutions working on the development of biopharmaceuticals. 354 pp. Englisch. Seller Inventory # 9783527328499
Book Description Wiley-Blackwell, 2012. Condition: New. book. Seller Inventory # M3527328491
Book Description Wiley-Blackwell, 2012. Hardcover. Condition: New. Never used!. Seller Inventory # P113527328491